Passage Bio, Inc. (NASDAQ:PASG – Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 316,300 shares, a decline of 17.6% from the December 31st total of 383,700 shares. Based on an average daily trading volume, of 626,300 […]
Passage Bio, Inc. (NASDAQ:PASG – Get Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 316,300 shares, a decrease of 17.6% from the December 31st total of 383,700 shares. Approximately 0.9% of the company’s stock are sold short. […]
Passage Bio, Inc. (NASDAQ:PASG – Free Report) – Equities research analysts at Wedbush cut their FY2023 EPS estimates for Passage Bio in a note issued to investors on Monday, November 13th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($1.96) for the year, down from their previous estimate […]
Passage Bio (NASDAQ:PASG – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03), MarketWatch Earnings reports. Passage Bio Price Performance NASDAQ PASG opened at $0.66 on Wednesday. The business has a fifty day moving average […]
Passage Bio (NASDAQ:PASG – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by ($0.03), MarketWatch Earnings reports. Passage Bio Price Performance PASG stock opened at $0.66 on Wednesday. Passage Bio has a 12 month low of […]